arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BIODESIX INC

BDSX

$23.49 ▲ +1.27 (+5.72%) at close

8 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

BIODESIX INC shows mixed fundamentals. On the positive side, Debt to Equity remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $177.4M

Dividend Yield —

Revenue Growth 24.1% ↘

Op. Margin -31.5% ↗

ROIC -46.3% ↘

FCF / Share $-3.12 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -20.29

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$88.50M

↑ +24.1% —

Net Income Profit after all expenses

$-35.27M

↑ +17.9% —

Operating Margin Operating profit as % of sales

-31.5%

↑ +34.9% 7th

FCF / Share Free cash flow per share

$-3.12

↑ +61.1% —

Long-Term Debt Long-term obligations

$50.01M

↑ +24.9% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	24.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+201%)	45.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+466%)	28.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+256%)	-29.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-474%)	19.6% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+146%)	85.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+969%)	—	—
EPS Growth YoY (%)	29.2% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	48.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	58.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	1.9% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	17.9% Good ↑ Good Improving Year-over-year change in net income	17.7% Good ↑ Good Improving Year-over-year change in net income	20.3% Good ↑ Good Improving Year-over-year change in net income	-51.6% Weak ↓ Weak Declining Year-over-year change in net income	-37.7% Weak Weak Year-over-year change in net income	-2.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	61.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	28.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	51.4% Excellent Excellent Year-over-year change in free cash flow	-3.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	32.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	9.4% Fair → Fair Stable Compound annual revenue growth over 3 years	2.5% Caution Caution Compound annual revenue growth over 3 years	15.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	14.2% Excellent Excellent Compound annual revenue growth over 5 years	23.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-31.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-310%)	-48.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-422%)	-84.2% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-661%)	-132.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-983%)	-75.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-601%)	-50.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-436%)	-108.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-826%)	—
Profit Margin (%) (%)	-39.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-432%)	-60.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-602%)	-106.2% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-985%)	-171.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1527%)	-79.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-760%)	-68.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-673%)	-125.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1143%)	—
FCF Margin (%) (%)	-26.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-72.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-93.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-126.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-55.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-51.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-93.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-46.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-73.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-78.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-164.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	9.4% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-31.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-54.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-53.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-59.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	-205.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1471%)	—	—	-218.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1559%)	-76.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-608%)	13.6% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-9%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	-20.29x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-3481%)	1.92x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+220%)	8.75x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1358%)	1.46x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+144%)	—	0.68x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+14%)	—	—
Interest Coverage (x)	-3.61x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.18x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.34x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.08x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$31.02M	$13.78M	$13.79M	$-12.96M	$-32.71M	$-34.05M	$-5.29M	—
Debt / EBITDA (x)	-1.79x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.16x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.97x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.60x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.22x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$11.72	$11.00	$11.96	$18.15	$39.84	—	—	—
Basic EPS, GAAP (USD)	$-4.67	$-6.60	$-12.80	$-31.00	$-31.60	—	—	—
Free Cash Flow per Share (USD)	$-3.12	$-8.00	$-11.15	$-22.93	$-22.26	—	—	—
Book Value per Share (USD)	$-0.30	$2.87	$0.95	$5.31	$12.81	$31.00	—	—
Tangible Book Value per Share (USD)	$-2.59	$-0.00	$-3.82	$-1.09	$-4.50	$9.69	—	—
Basic Weighted Avg Shares (shares)	7.55M	6.48M	4.11M	2.11M	1.37M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$15.08M	$25.17M	$6.27M	$30.50M	$14.65M	$54.02M	$-9.90M	—
LT Debt (USD)	$50.01M	$40.03M	$40.08M	$30.13M	—	$28.08M	—	—
Total Equity (USD)	$-2.46M	$20.88M	$4.58M	$20.61M	$19.73M	$41.17M	$-225.14M	$-194.63M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$88.50M	$71.32M	$49.09M	$38.21M	$54.51M	$45.56M	$24.55M	—
Net Income, GAAP (USD)	$-35.27M	$-42.93M	$-52.15M	$-65.45M	$-43.16M	$-31.35M	$-30.73M	—
Operating Cash Flow (USD)	$-23.27M	$-48.65M	$-22.87M	$-44.97M	$-28.22M	$-21.37M	$-21.73M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters

BIODESIX INC

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BDSX with peers